Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Amoxicillin development

Most methods used for the production of the commercially important a-amino penicillins, such as ampicillin and amoxicillin, are based on modifications of an enamine process employing the appropriate phenylglycine and methylacetoacetate followed by coupling with 6-APA (64). Other aspects of the fermentation, strain maintenance, equipment, inoculum development, media, and procedures used in the production of penicillin are well covered in previous editions of the Enyclopedia. Developments in these areas have been reviewed (65). [Pg.85]

A different approach has been used for the synthesis of amoxicillin (Figure 6.18). Based on the application of the inexpensive Dane salt of 4-hydroxyphenylglydne, a process has been developed giving the required compound in almost quantitative yield. [Pg.178]

Aspirin is avoided in breast-feeding because of the possibility of Reye s syndrome. Moreover if high doses of aspirin are used, the neonate may develop hypoprothrombinaemia. Benzodiazepines such as diazepam are present in milk and therefore should be avoided during breast-feeding. Amoxicillin can be safely administered during pregnancy and breast-feeding. [Pg.121]

Antibiotics. The history of antibiotics is one of remarkable success in saving lives. Penicillin, although discovered earlier, began to be manufactured for sale as a drug in 1942. Tetracycline followed in 1955 and amoxicillin in 1981. These, other variants developed over the years, and some new recent classes of antibiotics treat bacterial infections by killing the bacteria or preventing them from multiplying. In the process, they save lives and speed recovery. Except for some products sold for external use, antibiotics require a prescription. [Pg.50]

YM Li, A VanSchepdael, Y Zhu, E Rods, J Hoogmartens. Development and validation of amoxicillin determination by micellar electrokinetic capillary chromatography. J Chromatogr 812 227-236, 1998. [Pg.682]

Hoffman, A., et al. 1998. Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form. J Control Release 54 29. [Pg.67]

As mentioned in the Introduction, bacterial resistance to currently used antibacterial agents poses a major threat to their continued effectiveness [2]. Interestingly, a number of enzymes are involved in the development of antibacterial resistance via several mechanisms. For example, there are enzymes that catalyze the inactivation of antibacterial agents [47], 3-Lactamases are the best-known examples of this class of enzymes and have been studied extensively as targets for new inhibitors that are used in combination with 3-lactams to prevent their inactivation [48], Several [3-lactamase inhibitors have been developed and are used in combination with [3-lactams (e.g., amoxicillin/clavulanic acid, piperacillin/tazo-bactam, and others) [49,50],... [Pg.250]

The C-6 side-chain functions of antibiotics have been used to develop the pro-dual-drug concept <2002BMC3489>. Compounds 64 and 65, combining clavulanic acid and amoxicillin, show a notable activity against /3-lactamase-producing microorganisms. [Pg.206]

Dr. David Johnson (1975-1982). Of all my senior managers, Dave Johnson was the one who knew most about organic chemistry and synthesis. He was a hard-driving chemist with a nose for practical solutions to process development problems. Being a student of Professor John Sheehan, his knowledge of (3-lactam chemistry was extensive. Indeed he was called on to represent Bristol-Myers in its many patent battles with Beecham in which Bristol-Myers staked out its own patent position covering ampicillin and amoxicillin trihydrates.8... [Pg.14]

In reaching its decision to launch Amoxicillin on the Japanese market, Bristol-Myers had recognized the need to design around the Beecham patent and identify and develop a process which would be competitive. [Pg.153]

Bristol-Myers built on Eli Lilly s discovery of Cephalexin by funding the research that led to the development of Cefadroxil (VIII), just as Beecham had done in building on its own discovery of ampicillin with the invention of amoxicillin. Both amoxicillin and cefadroxil carried the i>(-)/>hydroxyphenylglycyl side chain which served to extend biological activity and increase blood levels versus ampicillin and Cephalexin. [Pg.214]

Several natural penicillins can be produced, depending on the chemical composition of the fermentation medium used to culture penicillium. Penicillin G (benzylpenicillin) has the greatest antimicrobial activity of these natural penicillins and is the only natural penicillin used clinically. However, penicillin G is not stable it is extremely acid-labile. Only about one-third of an oral dose is absorbed under the most ideal conditions. Therefore, it is generally not given orally but is administered by intramuscular injection. Several newer derivatives of penicillin G have been developed that do have good to excellent oral absorption (e.g., cloxacillin, ampicillin, and amoxicillin). [Pg.168]

Answer B (Amoxicillin). The multiple extractions can lead to bacteremia while the mitral valve stenosis and cardiac insufficiency place him at risk for developing endocarditis. The present American Heart Association guidelines indicate amoxicillin (3 gm 1 hour prior to procedure and 1.5 gm 6 hours after original dose.) Vancomycin would only be appropriate if the patient was allergic to penicillins. Tetracycline and cotrimoxazole are bacteriostatic and not effective against the viridans group of Streptococci, the usual causative organism. Imipenem is also inappropriate since its spectrum is too broad. [Pg.320]

As a result of the urethral catheter she had inserted in the intensive care unit, CM develops a urinary tract infection, with an E. coli that is resistant to trimethoprim and amoxicillin, but is sensitive to gentamicin. She is prescribed a dose of gentamicin, 7 mg/kg intravenously once daily for 5 days. [Pg.362]

White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. Augmentin amoxicillin/clavulanate in the treatment of community-acquired respiratory tract infection a review of the continuing development of an innovative antimicrobial agent. J. Antimicrob. Chemother. 2004 53 3-20. [Pg.1475]

Clavulanic acid has a very low immunogenic and allergenic potential in animals. The possible impact of its co-administration with other beta-lactam antibiotics is unknown (53). Two patients with IgE-mediated hypersensitivity to oral co-amoxiclav and positive skin tests for clavulanic acid, but not for penicillins, both tolerated oral amoxicillin. One patient was also challenged with clavulanic acid and developed urticaria, conjunctivitis, and bronchial obstruction (54). Since co-amoxiclav has been widely used since its introduction in 1981, the frequency of hypersensitivity reactions is low. The clinical data available on sulbactam and tazobactam are stiU hm-ited and do not allow an assessment of the frequency and pattern of associated hypersensitivity reactions (55). [Pg.504]


See other pages where Amoxicillin development is mentioned: [Pg.252]    [Pg.1103]    [Pg.1157]    [Pg.49]    [Pg.520]    [Pg.69]    [Pg.256]    [Pg.182]    [Pg.205]    [Pg.167]    [Pg.310]    [Pg.622]    [Pg.531]    [Pg.603]    [Pg.42]    [Pg.122]    [Pg.356]    [Pg.981]    [Pg.907]    [Pg.356]    [Pg.3]    [Pg.440]    [Pg.443]    [Pg.164]    [Pg.132]    [Pg.223]    [Pg.299]    [Pg.13]    [Pg.116]    [Pg.411]    [Pg.239]    [Pg.694]    [Pg.2027]   
See also in sourсe #XX -- [ Pg.14 ]




SEARCH



Amoxicillin

© 2024 chempedia.info